Jim Wil­son se­cures $100M for glob­al ap­proach aimed at re­viv­ing gene ther­a­py field

A gene ther­a­py pi­o­neer thinks he has a so­lu­tion to the field’s strug­gle to com­mer­cial­ize break­through cures: Go glob­al.

Jim Wil­son’s Philadel­phia-based com­pa­ny Gem­ma­Bio on …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER